Abstract:OBJECTIVE:To study the effects of RNA interference (RNAi)-mediated insulin-like growth factor I receptor (IGF-IR) gene silencing on human lung cancer cells. METHODS:Plasmids expressing IGF-IR shRNA1 and IGF-IR shRNA2 were constructed. Human non-small cell lung cancer cells of the line A549 were cultured and transfected with sequence-specific shRNA. RT-PCR was used to monitor the IGF-IR mRNA expression. Western blotting was used to detect the expression of IGF-IR, bcl-2 and caspase-3, associated with apoptosis, and IGF-IR signaling pathways-associated proteins, total and phospho-ERK1/2 and Akt. MTT assay and flow cytometry were used to examine the cell activity and cell cycle. Twelve nude mice were injected subcutaneously with A549 cells, 20 days later the mice were randomly divided into 3 groups to be injected into the tumor with IGF-IR, PBS, or blank plasmid respectively 4 times with the interval of 5 days. Five days after the 4th injection the mice were killed and the tumors were taken out. TUNNEL assay was used to detect the apoptotic cell in the tumor. RESULTS:RT-PCR showed that the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA1 was only 24% +/- 4% that of the A549 cells transfected with blank plasmid (P < 0.05); however, the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA2 was 78% +/- 5% that of the A549 cells transfected with blank plasmid (P > 0.05). The IGF-IR protein expression level of the A549 cells of the IGF-IR shRNA1 group was only 10.2% +/- 2.8% that of the A549 cells of the blank plasmid group (P < 0.05). Western blotting showed that the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA1 group were 46% +/- 6% and 156% +/- 8% those of the negative controls (both P < 0.05); however, the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA2 group were not different from those of the negative control cells. The Akt kinase and ERK phosphorylation levels of the A549 cells of the IGF-IR shRNA1 group were 10% and 36% +/- 3% those of the negative control cells respectively (both P < 0.05). Since 48h after the transfection the active cell number of the IGF-IR shRNA1 group was 64% +/- 7% that of the negative group (P < 0.05), and this decrease effect lasted to 72 h after (67% +/- 6% that of the negative cells, P < 0.05). 48 h after the transfection the percentage of cells at G(0)/G(1) phase of the IGF-IR shRNA1 group was 77.5%, significantly higher than that of the negative control group, and the percentages of the cells at S and G(2)/M phases of the IGF-IR shRNA1 group were 15.7% and 7.3% respectively, both significantly lower than those of the negative control group (23.0% and 29.9% respectively). Since the second injection the tumor size of the mice of IGF-IR shRNA group was 40% - 50% that of the PBS group (P < 0.05), and the tumor size of the mice of the PBS group was 90% that of the control group. TUNNEL assay showed that the number of apoptotic cells in the tumors of the IGF-IR shRNA1 group mice was 118 +/- 8/high power, significantly higher than that of the control group (70 +/- 9, P < 0.05). CONCLUSION:RNAi technique effectively inhibits the expression of IGF-IR, thus decreasing the NSCLC cell proliferation inducing apoptosis and inhibiting the tumor growth.

Inhibitory effect of RNA interference on expression of rat ICOS in vitro

Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats

Efficient Inhibition of Human Cytomegalovirus UL122 Gene Expression in Cell by Small Interfering RNAs

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

Construction and identification of small hairpin RNA expression plasmid targeting opticin gene in rat

Screening for Sirna Sequence Targeting Rat Toll-like Receptor 4 Mrna in Vitro

[Effects of RNAi on Cyclooxygenase-2 Expression and Biologic Activity of Human Rheumatoid Arthritis Synovial Fibroblasts].

STUDY ON INHIBITION OF EXPRESSION OF HUMAN NUCLEAR RECEPTOR NR5A2 VIA RNA INTERFERENCE MEDIATED BY SIRNA EXPRESSING VECTOR

High Doses of Sirnas Induce Eri-1 and Adar-1 Gene Expression and Reduce the Efficiency of RNA Interference in the Mouse

Construction of Recombinant Lentivirus Vector Expressing Small Hairpin RNA Against Human Bax Inhibitor-1 Gene Expression

Conditional RNA interference in mammalian cells via RNA transactivation

Inhibitory effect of specific siRNA on CVB3-VP1 expression in HeLa cells

Expression of Recombinant Human ICOS and in Vitro Characterization of Its Bioactivity on B Lymphocytes.

Blockade of OX40/OX40L Pathway Promotes CD4 + CD25 + T Regulatory Cells Proliferation

RNA Interference Effectively Inhibits Mrna Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells

[Inhibition of HLA-DRB1*0405 Gene Expression by Sirna].

[RNA Interference in Three ES Cell Lines from Different Mouse Strains].

[Shrna-Mediated Insulin-Like Growth Factor I Receptor Gene Silencing Inhibits Cell Proliferation, Induces Cell Apoptosis, and Suppresses Tumor Growth in Non-Small Cell Lung Cancer: in Vitro and in Vivo Experiments].

Inhibition Effects of RNAi on KDR Protein Expression in Osteosacoma Cells

In Vitro Inhibition of Lipoprotein Lipase Gene Expression by RNA Interference

Construction of Cannabinoid Receptor 1 Gene(CNR1) Sirna Expression Vector and Screening of CNR1-interference Positive L6 Cell Clones